• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Targeted exome sequencing for molecular diagnosis of pediatric Alport syndrome in Southwest China.中国西南地区儿童遗传性肾炎分子诊断的靶向外显子组测序
Front Genet. 2025 Aug 29;16:1580864. doi: 10.3389/fgene.2025.1580864. eCollection 2025.
2
Alport Syndrome阿尔波特综合征
3
Novel COL4A3-COL4A5 variants and digenic inheritance in pediatric Alport syndrome from Southwestern China.中国西南地区小儿Alport综合征中的新型COL4A3-COL4A5变异体及双基因遗传
Sci Rep. 2025 Aug 25;15(1):31313. doi: 10.1038/s41598-025-17027-9.
4
Lithuanian Study on and Genetic Variants in Alport Syndrome: Clinical Characterization of 52 Individuals from 38 Families.立陶宛关于阿尔波特综合征中[具体内容缺失]和基因变异的研究:来自38个家庭的52名个体的临床特征
Int J Mol Sci. 2025 Aug 7;26(15):7639. doi: 10.3390/ijms26157639.
5
Case Report: Whole genome sequencing identifies a novel deep intronic variant of uncertain significance in X-linked Alport syndrome.病例报告:全基因组测序在X连锁遗传性肾炎中鉴定出一种意义未明的新型内含子深部变异。
Front Pediatr. 2025 Aug 7;13:1639471. doi: 10.3389/fped.2025.1639471. eCollection 2025.
6
Genotype-Based Molecular Mechanisms in Alport Syndrome.阿尔波特综合征基于基因型的分子机制
J Am Soc Nephrol. 2025 Jun 1;36(6):1176-1183. doi: 10.1681/ASN.0000000647. Epub 2025 Feb 3.
7
A Novel Loss-of-Function Variant in COL4A3 in a Consanguineous Moroccan Family Displaying the Alport Syndrome with Variable Clinical Expression.在一个患有临床表现各异的奥尔波特综合征的摩洛哥近亲家庭中,发现COL4A3基因存在一种新型功能丧失变异。
Mol Syndromol. 2025 Feb;16(1):43-48. doi: 10.1159/000540122. Epub 2024 Jul 24.
8
Potential Renal Damage Biomarkers in Alport Syndrome-A Review of the Literature.Alport 综合征潜在的肾损伤生物标志物研究进展。
Int J Mol Sci. 2022 Jun 30;23(13):7276. doi: 10.3390/ijms23137276.
9
Identification of 27 Novel Variants in Genes , and in Lithuanian Families With Alport Syndrome.在立陶宛阿尔波特综合征家族中鉴定出基因、和中的27个新变异体。
Front Med (Lausanne). 2022 Mar 28;9:859521. doi: 10.3389/fmed.2022.859521. eCollection 2022.
10
Alport syndrome and Alport kidney diseases - elucidating the disease spectrum.Alport 综合征及 Alport 肾脏疾病——阐明疾病谱。
Curr Opin Nephrol Hypertens. 2024 May 1;33(3):283-290. doi: 10.1097/MNH.0000000000000983. Epub 2024 Mar 13.

本文引用的文献

1
Diagnosis, management and treatment of the Alport syndrome - 2024 guideline on behalf of ERKNet, ERA and ESPN.奥尔波特综合征的诊断、管理与治疗——2024年代表ERKNet、ERA和ESPN发布的指南
Nephrol Dial Transplant. 2025 May 30;40(6):1091-1106. doi: 10.1093/ndt/gfae265.
2
Alport Syndrome: Clinical Spectrum and Therapeutic Advances.奥尔波特综合征:临床谱与治疗进展
Kidney Med. 2023 Mar 21;5(5):100631. doi: 10.1016/j.xkme.2023.100631. eCollection 2023 May.
3
Dissecting the genotype-phenotype correlation of COL4A5 gene mutation and its response to renin-angiotensin-aldosterone system blockers in Chinese male patients with Alport syndrome.解析 COL4A5 基因突变的基因型-表型相关性及其对中国男性 Alport 综合征患者肾素-血管紧张素-醛固酮系统阻滞剂的反应。
Nephrol Dial Transplant. 2022 Nov 23;37(12):2487-2495. doi: 10.1093/ndt/gfac002.
4
Functional assessment of a novel splicing site variant in a Chinese X-linked Alport syndrome family.对一个中国X连锁遗传性肾炎家系中一个新的剪接位点变异体的功能评估。
Ann Transl Med. 2021 Sep;9(18):1420. doi: 10.21037/atm-21-3523.
5
Consensus statement on standards and guidelines for the molecular diagnostics of Alport syndrome: refining the ACMG criteria.关于 Alport 综合征分子诊断标准和指南的共识声明:完善 ACMG 标准。
Eur J Hum Genet. 2021 Aug;29(8):1186-1197. doi: 10.1038/s41431-021-00858-1. Epub 2021 Apr 15.
6
Genotype-phenotype correlations and nephroprotective effects of RAAS inhibition in patients with autosomal recessive Alport syndrome.常染色体隐性遗传性 Alport 综合征患者的 RAAS 抑制的基因型-表型相关性及肾脏保护作用。
Pediatr Nephrol. 2021 Sep;36(9):2719-2730. doi: 10.1007/s00467-021-05040-9. Epub 2021 Mar 27.
7
Alport Syndrome: A Comprehensive Review on Genetics, Pathophysiology, Histology, Clinical and Therapeutic Perspectives.Alport 综合征:遗传学、病理生理学、组织学、临床和治疗观点的全面综述。
Curr Med Chem. 2021;28(27):5602-5624. doi: 10.2174/0929867328666210108113500.
8
Clinical practice recommendations for the diagnosis and management of Alport syndrome in children, adolescents, and young adults-an update for 2020.临床实践推荐:儿童、青少年及青年 Alport 综合征的诊断与管理——2020 年更新。
Pediatr Nephrol. 2021 Mar;36(3):711-719. doi: 10.1007/s00467-020-04819-6. Epub 2020 Nov 6.
9
Alport Syndrome: Achieving Early Diagnosis and Treatment.阿尔波特综合征:实现早期诊断和治疗。
Am J Kidney Dis. 2021 Feb;77(2):272-279. doi: 10.1053/j.ajkd.2020.03.026. Epub 2020 Jul 22.
10
A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport's syndrome.一项多中心、随机、安慰剂对照、双盲3期试验及开放组比较表明,赖诺普利对Alport综合征患儿进行肾保护治疗具有安全性和有效性。
Kidney Int. 2020 Jun;97(6):1275-1286. doi: 10.1016/j.kint.2019.12.015. Epub 2020 Jan 17.

中国西南地区儿童遗传性肾炎分子诊断的靶向外显子组测序

Targeted exome sequencing for molecular diagnosis of pediatric Alport syndrome in Southwest China.

作者信息

Zhou Cong, Xiao Yuanyuan, Wei Xing, Wang Jing, Liu Shanling

机构信息

Department of Medical Genetics / Prenatal Diagnostic Center, West China Second University Hospital, Sichuan University, Chengdu, China.

Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, China.

出版信息

Front Genet. 2025 Aug 29;16:1580864. doi: 10.3389/fgene.2025.1580864. eCollection 2025.

DOI:10.3389/fgene.2025.1580864
PMID:40949880
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12425891/
Abstract

BACKGROUND

Alport syndrome (AS) is an inherited disorder affecting basement membrane collagen IV. AS is characterized by hematuria and progressive renal failure, accompanied by high-frequency sensorineural deafness and ocular changes. AS is caused by collagen type IV α3 chain (), α4 chain (), and α5 chain () variants. We aimed to identify the genetic variants in a cohort of 20 children with clinically suspected AS in Southwest China.

RESULTS

We detected 21 , , and variants in 20 probands. Of these variants, 16 (16/21, 76.2%) were classified as pathogenic/likely pathogenic and 5 (5/21, 23.8%) of uncertain significance according to the American College of Medical Genetics and Genomics criteria. A total of 11 (11/21, 52.4%) and 10 (10/21, 47.6%) variants were known and novel, respectively.

CONCLUSION

We performed molecular diagnosis on 15 patients using targeted exome sequencing. Our findings indicate additional , , and variants as involved in AS, having implications for genetic diagnosis, therapy, and counseling of affected families.

摘要

背景

Alport综合征(AS)是一种影响基底膜胶原蛋白IV的遗传性疾病。AS的特征为血尿和进行性肾衰竭,伴有高频感音神经性耳聋和眼部改变。AS由IV型胶原蛋白α3链()、α4链()和α5链()变异引起。我们旨在确定中国西南部20名临床疑似AS儿童队列中的基因变异。

结果

我们在20名先证者中检测到21种、和变异。根据美国医学遗传学与基因组学学会标准,这些变异中,16种(16/21,76.2%)被分类为致病性/可能致病性,5种(5/21,23.8%)意义不明确。分别共有11种(11/21,52.4%)和10种(10/21,47.6%)变异是已知的和新发现的。

结论

我们使用靶向外显子组测序对15名患者进行了分子诊断。我们的研究结果表明,还有其他、和变异与AS有关,这对受影响家庭的基因诊断、治疗和咨询具有重要意义。